Also, T cells specific for viral oncogene products in virus-induced cancers as well as self-antigens upregulated in tumors relative to normal cells—so called tumor-associated antigens (TAA)—have been identified, which can further contribute to PD-1 blockade-induced anti-tumor responses. Here, PDCD1 is linked to neoplasm.